Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Errin Roy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Cell and Developmental Biology|February 23, 2023
3D multicellular systems in disease modelling: From organoids to organ-on-chipCaoimhe Goldrick, Ina Guri, Gabriel Herrera-Oropeza, et al.
Frontiers in Bioengineering and Biotechnology|November 26, 2024
Morphogen-driven differentiation is precluded by physical confinement in human iPSCs spheroidsHaneen S Alsehli, Errin Roy, Thomas Williams, et al.
Journal of Cell Science|January 4, 2022
High-content image analysis to study phenotypic heterogeneity in endothelial cell monolayersFrancois Chesnais, Jonas Hue, Errin Roy, et al.
Nature Communications|December 4, 2021
Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcomaGeorgia Zoumpoulidou, Carlos Alvarez-Mendoza, Caterina Mancusi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Cell and Developmental Biology|February 23, 2023
3D multicellular systems in disease modelling: From organoids to organ-on-chipCaoimhe Goldrick, Ina Guri, Gabriel Herrera-Oropeza, et al.
Frontiers in Bioengineering and Biotechnology|November 26, 2024
Morphogen-driven differentiation is precluded by physical confinement in human iPSCs spheroidsHaneen S Alsehli, Errin Roy, Thomas Williams, et al.
Journal of Cell Science|January 4, 2022
High-content image analysis to study phenotypic heterogeneity in endothelial cell monolayersFrancois Chesnais, Jonas Hue, Errin Roy, et al.
Nature Communications|December 4, 2021
Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcomaGeorgia Zoumpoulidou, Carlos Alvarez-Mendoza, Caterina Mancusi, et al.
Pageof 1